Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus
Gespeichert in:
| Veröffentlicht in: | Endocrine 2014-12, Vol.47 (3), p.962-964 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 964 |
|---|---|
| container_issue | 3 |
| container_start_page | 962 |
| container_title | Endocrine |
| container_volume | 47 |
| creator | Okada, Kenta Kotani, Kazuhiko Yagyu, Hiroaki Ando, Akihiko Osuga, Jun-ichi Ishibashi, Shun |
| description | |
| doi_str_mv | 10.1007/s12020-014-0246-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4239782</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1627075112</sourcerecordid><originalsourceid>FETCH-LOGICAL-c512t-bea02aeaeb439cefd581663c1bf521671d258386e12bd84fdc71157097edeed63</originalsourceid><addsrcrecordid>eNp9kc1u1TAQhS0Eon88ABvkJZsU24ntZIOEqvIjVWJDpe4sx57cukqc4HEu9BV4anybUsGGlS3Pd87M-BDymrNzzph-h1wwwSrGm4qJRlXqGTnmUnblhbHn5V5LWTHW3hyRE8Q7xoQQSr8kRwXuFOv0Mfl1OQzgMtJ5oDmBzRPETH-EfEvHkOxuXHPwQOdI55_B2xz2QLGAiNRGT51NPlhHo80prAlycHSB5UEzwh5GpCHSpeiKLW6--X4BKmjR9ZAB6QTjGPKKZ-TFYEeEV4_nKbn-ePnt4nN19fXTl4sPV5WTXOSqB8uEBQt9U3cOBi9brlTteD9IwZXmXsi2bhVw0fu2GbzTnEtdtgUP4FV9St5vvsvaT-BdmSzZ0SwpTDbdm9kG828lhluzm_emEXWnW1EM3j4apPn7CpjNFNCVLWyEeUXDldBMS84PKN9Ql2bEBMNTG87MIUOzZWhKhuaQoTnM9-bv-Z4Uf0IrgNgALKW4g2Tu5jXF8mf_cf0NVLmsEQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1627075112</pqid></control><display><type>article</type><title>Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus</title><source>MEDLINE</source><source>SpringerLink (Online service)</source><creator>Okada, Kenta ; Kotani, Kazuhiko ; Yagyu, Hiroaki ; Ando, Akihiko ; Osuga, Jun-ichi ; Ishibashi, Shun</creator><creatorcontrib>Okada, Kenta ; Kotani, Kazuhiko ; Yagyu, Hiroaki ; Ando, Akihiko ; Osuga, Jun-ichi ; Ishibashi, Shun</creatorcontrib><identifier>ISSN: 1355-008X</identifier><identifier>EISSN: 1559-0100</identifier><identifier>DOI: 10.1007/s12020-014-0246-6</identifier><identifier>PMID: 24696097</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Aged ; Diabetes ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes Mellitus, Type 2 - metabolism ; Endocrinology ; Female ; Glucagon-Like Peptide 1 - analogs & derivatives ; Glucagon-Like Peptide 1 - pharmacology ; Glucagon-Like Peptide 1 - therapeutic use ; Humanities and Social Sciences ; Humans ; Hypoglycemic Agents - pharmacology ; Hypoglycemic Agents - therapeutic use ; Internal Medicine ; Liraglutide ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; multidisciplinary ; Natriuretic Peptide, C-Type - blood ; Oxidative Stress - drug effects ; Research Letter ; Science</subject><ispartof>Endocrine, 2014-12, Vol.47 (3), p.962-964</ispartof><rights>The Author(s) 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c512t-bea02aeaeb439cefd581663c1bf521671d258386e12bd84fdc71157097edeed63</citedby><cites>FETCH-LOGICAL-c512t-bea02aeaeb439cefd581663c1bf521671d258386e12bd84fdc71157097edeed63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12020-014-0246-6$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12020-014-0246-6$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24696097$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Okada, Kenta</creatorcontrib><creatorcontrib>Kotani, Kazuhiko</creatorcontrib><creatorcontrib>Yagyu, Hiroaki</creatorcontrib><creatorcontrib>Ando, Akihiko</creatorcontrib><creatorcontrib>Osuga, Jun-ichi</creatorcontrib><creatorcontrib>Ishibashi, Shun</creatorcontrib><title>Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus</title><title>Endocrine</title><addtitle>Endocrine</addtitle><addtitle>Endocrine</addtitle><subject>Aged</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - metabolism</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Glucagon-Like Peptide 1 - analogs & derivatives</subject><subject>Glucagon-Like Peptide 1 - pharmacology</subject><subject>Glucagon-Like Peptide 1 - therapeutic use</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Internal Medicine</subject><subject>Liraglutide</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>multidisciplinary</subject><subject>Natriuretic Peptide, C-Type - blood</subject><subject>Oxidative Stress - drug effects</subject><subject>Research Letter</subject><subject>Science</subject><issn>1355-008X</issn><issn>1559-0100</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><recordid>eNp9kc1u1TAQhS0Eon88ABvkJZsU24ntZIOEqvIjVWJDpe4sx57cukqc4HEu9BV4anybUsGGlS3Pd87M-BDymrNzzph-h1wwwSrGm4qJRlXqGTnmUnblhbHn5V5LWTHW3hyRE8Q7xoQQSr8kRwXuFOv0Mfl1OQzgMtJ5oDmBzRPETH-EfEvHkOxuXHPwQOdI55_B2xz2QLGAiNRGT51NPlhHo80prAlycHSB5UEzwh5GpCHSpeiKLW6--X4BKmjR9ZAB6QTjGPKKZ-TFYEeEV4_nKbn-ePnt4nN19fXTl4sPV5WTXOSqB8uEBQt9U3cOBi9brlTteD9IwZXmXsi2bhVw0fu2GbzTnEtdtgUP4FV9St5vvsvaT-BdmSzZ0SwpTDbdm9kG828lhluzm_emEXWnW1EM3j4apPn7CpjNFNCVLWyEeUXDldBMS84PKN9Ql2bEBMNTG87MIUOzZWhKhuaQoTnM9-bv-Z4Uf0IrgNgALKW4g2Tu5jXF8mf_cf0NVLmsEQ</recordid><startdate>20141201</startdate><enddate>20141201</enddate><creator>Okada, Kenta</creator><creator>Kotani, Kazuhiko</creator><creator>Yagyu, Hiroaki</creator><creator>Ando, Akihiko</creator><creator>Osuga, Jun-ichi</creator><creator>Ishibashi, Shun</creator><general>Springer US</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20141201</creationdate><title>Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus</title><author>Okada, Kenta ; Kotani, Kazuhiko ; Yagyu, Hiroaki ; Ando, Akihiko ; Osuga, Jun-ichi ; Ishibashi, Shun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c512t-bea02aeaeb439cefd581663c1bf521671d258386e12bd84fdc71157097edeed63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - metabolism</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Glucagon-Like Peptide 1 - analogs & derivatives</topic><topic>Glucagon-Like Peptide 1 - pharmacology</topic><topic>Glucagon-Like Peptide 1 - therapeutic use</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Internal Medicine</topic><topic>Liraglutide</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>multidisciplinary</topic><topic>Natriuretic Peptide, C-Type - blood</topic><topic>Oxidative Stress - drug effects</topic><topic>Research Letter</topic><topic>Science</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Okada, Kenta</creatorcontrib><creatorcontrib>Kotani, Kazuhiko</creatorcontrib><creatorcontrib>Yagyu, Hiroaki</creatorcontrib><creatorcontrib>Ando, Akihiko</creatorcontrib><creatorcontrib>Osuga, Jun-ichi</creatorcontrib><creatorcontrib>Ishibashi, Shun</creatorcontrib><collection>Springer Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Endocrine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Okada, Kenta</au><au>Kotani, Kazuhiko</au><au>Yagyu, Hiroaki</au><au>Ando, Akihiko</au><au>Osuga, Jun-ichi</au><au>Ishibashi, Shun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus</atitle><jtitle>Endocrine</jtitle><stitle>Endocrine</stitle><addtitle>Endocrine</addtitle><date>2014-12-01</date><risdate>2014</risdate><volume>47</volume><issue>3</issue><spage>962</spage><epage>964</epage><pages>962-964</pages><issn>1355-008X</issn><eissn>1559-0100</eissn><cop>Boston</cop><pub>Springer US</pub><pmid>24696097</pmid><doi>10.1007/s12020-014-0246-6</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1355-008X |
| ispartof | Endocrine, 2014-12, Vol.47 (3), p.962-964 |
| issn | 1355-008X 1559-0100 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4239782 |
| source | MEDLINE; SpringerLink (Online service) |
| subjects | Aged Diabetes Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - metabolism Endocrinology Female Glucagon-Like Peptide 1 - analogs & derivatives Glucagon-Like Peptide 1 - pharmacology Glucagon-Like Peptide 1 - therapeutic use Humanities and Social Sciences Humans Hypoglycemic Agents - pharmacology Hypoglycemic Agents - therapeutic use Internal Medicine Liraglutide Male Medicine Medicine & Public Health Middle Aged multidisciplinary Natriuretic Peptide, C-Type - blood Oxidative Stress - drug effects Research Letter Science |
| title | Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T13%3A14%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20treatment%20with%20liraglutide%20on%20oxidative%20stress%20and%20cardiac%20natriuretic%20peptide%20levels%20in%20patients%20with%20type%202%20diabetes%20mellitus&rft.jtitle=Endocrine&rft.au=Okada,%20Kenta&rft.date=2014-12-01&rft.volume=47&rft.issue=3&rft.spage=962&rft.epage=964&rft.pages=962-964&rft.issn=1355-008X&rft.eissn=1559-0100&rft_id=info:doi/10.1007/s12020-014-0246-6&rft_dat=%3Cproquest_pubme%3E1627075112%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1627075112&rft_id=info:pmid/24696097&rfr_iscdi=true |